Bariatric News
@BariatricNews
Bringing you the latest news, events, and opinions about weight loss surgery and associated metabolic disorders since 2009.
ID:533137719
http://www.bariatricnews.net 22-03-2012 11:24:20
9,2K Tweets
8,4K Followers
1,2K Following
#Tirzepatide reduces sleep apnoea severity in up to nearly two-thirds in adults living with OSA & #obesity
SURMOUNT-OSA RCT results showed tirzepatide injection (10mg or 15mg) significantly reduced the apnoea-hypopnea index vs placebo Eli Lilly and Company tinyurl.com/45xsr9k4
Join us June 8 in San Diego for Poriesevent.org and ASMBSmeeting.com ! Don't miss out,Register TODAY!
ASMBS IFSO International Bariatric Club SAGES Is In Cleveland 2024! Dr Eric DeMaria Monique Hassan, MD, MBA, FACS, FASMBS, DABOM Daniel Jones Ali Aminian Matthew Kroh, MD Jeffrey Ponsky Neil Floch MD
Outstanding Conference with some of the top leaders in obesity research and treatment! I was honored to attend! Pennington Biomedical Research Center LSU Health Sciences Dr. John Kirwan Donna Ryan Leanne M. Redman, PhD Caroline Apovian MD Jamy D. Ard The Obesity Society World Obesity Vance L. Albaugh, MD, PhD, FACS, FASMBS ASMBS IFSO
This week's Bariatric News' Journal Watch includes #semaglutide vs ESG, 3D vs 2D video systems in bariatric surgery, psychological & psychosocial differences when undergoing surgery, surgery & serum uric acid levels, internalised weight stigma, & more tinyurl.com/ywnm6uae
Bariatric News caught up with Dr Ahmad Aly, co-organising President of #ifso2024 to preview some of the key sessions, what’s new at this year’s meeting & what the beautiful city of Melbourne has to offer visiting delegates IFSO IFSO MENAC (Middle East North Africa Chapter) tinyurl.com/yssjm75d
There is no causal association between the GLP-1 receptor agonists – dulaglutide, exenatide, liraglutide, lixisenatide & semaglutide – & suicidal & self-injurious thoughts & actions, the Pharmacovigilance Risk Assessment Committee EU Medicines Agency has concluded tinyurl.com/2f9wjxa4
Catch up with Bariatric News: IFSO Global Registry, CMS' semaglutide expansion could save millions of lives, Tirzepatide linked with a potential targeted effect on visceral & liver fat, nerve stimulation for OSA less effective for people with high BMIs tinyurl.com/bdcth6zn
The latest paper from the IFSO Global Registry Collaboration represents the key findings of the eighth report of the IFSO Global Registry, including data from 24 national & 2 regional registries, totalling 502,150 procedures IFSO IFSO MENAC (Middle East North Africa Chapter) tinyurl.com/47n7p4vy
SURPASS-3 MRI study reveals significant reduction of visceral- & liver fat z-scores, & a shift towards a more balanced fat distribution pattern with tirzepatide treatment, according to AMRA® Official Eli Lilly and Company Nantes Université University Hospitals Linköpings universitet tinyurl.com/39hf7ssk